Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by abnormal activation of the immune system, leading to damage of the body′s own tissues and organs. The exact mechanisms underlying the pathogenesis of SLE remain incompletely understood. Increasing evidence underscores the significant role of dietary and nutritional factors in the onset, progression, and management of SLE. Modifications in dietary patterns and nutritional interventions offer a promising strategy for improving clinical outcomes and enhancing the quality of life in patients with SLE. This article synthesizes recent basic and clinical research on the impact of various nutritional elements and dietary approaches on the development, progression, and treatment of SLE. It also explores the mechanisms at different levels, aiming to provide valuable insights for future research in this area.

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by abnormal activation of the immune system, leading to damage of the body′s own tissues and organs. The exact mechanisms underlying the pathogenesis of SLE remain incompletely understood. Increasing evidence underscores the significant role of dietary and nutritional factors in the onset, progression, and management of SLE. Modifications in dietary patterns and nutritional interventions offer a promising strategy for improving clinical outcomes and enhancing the quality of life in patients with SLE. This article synthesizes recent basic and clinical research on the impact of various nutritional elements and dietary approaches on the development, progression, and treatment of SLE. It also explores the mechanisms at different levels, aiming to provide valuable insights for future research in this area.

Off-label drug use,being urgent and rational under certain circumstances,has existed in clinical practice all the time.While the academic community is divided on this issue,resolving the balance between ensuring the safety of medicines for the public and the availability of medicines for certain groups of the population remains a major concern of the society,but to favour either side is to neglect the defence of the rights of the other side.The implementation of"Law on Practicing Doctors of the People's Republic of China"brings new opportunities and requirements for off-label drug use.With the causes and ethical certification of off-label drug use as a starting point,it holds to the premise of strictly controlling the applicable conditions of off-label drug use and brings forward countermeasures of laws and regulations for the following three aspects:the realization of legal involvement and cohesion of off-label drug use,the issue of unified standards for evidence-based medicine and the encouragement of updating and replacing drug specifications.

Off-label drug use,being urgent and rational under certain circumstances,has existed in clinical practice all the time.While the academic community is divided on this issue,resolving the balance between ensuring the safety of medicines for the public and the availability of medicines for certain groups of the population remains a major concern of the society,but to favour either side is to neglect the defence of the rights of the other side.The implementation of"Law on Practicing Doctors of the People's Republic of China"brings new opportunities and requirements for off-label drug use.With the causes and ethical certification of off-label drug use as a starting point,it holds to the premise of strictly controlling the applicable conditions of off-label drug use and brings forward countermeasures of laws and regulations for the following three aspects:the realization of legal involvement and cohesion of off-label drug use,the issue of unified standards for evidence-based medicine and the encouragement of updating and replacing drug specifications.

Off-label drug use,being urgent and rational under certain circumstances,has existed in clinical practice all the time.While the academic community is divided on this issue,resolving the balance between ensuring the safety of medicines for the public and the availability of medicines for certain groups of the population remains a major concern of the society,but to favour either side is to neglect the defence of the rights of the other side.The implementation of"Law on Practicing Doctors of the People's Republic of China"brings new opportunities and requirements for off-label drug use.With the causes and ethical certification of off-label drug use as a starting point,it holds to the premise of strictly controlling the applicable conditions of off-label drug use and brings forward countermeasures of laws and regulations for the following three aspects:the realization of legal involvement and cohesion of off-label drug use,the issue of unified standards for evidence-based medicine and the encouragement of updating and replacing drug specifications.

Off-label drug use,being urgent and rational under certain circumstances,has existed in clinical practice all the time.While the academic community is divided on this issue,resolving the balance between ensuring the safety of medicines for the public and the availability of medicines for certain groups of the population remains a major concern of the society,but to favour either side is to neglect the defence of the rights of the other side.The implementation of"Law on Practicing Doctors of the People's Republic of China"brings new opportunities and requirements for off-label drug use.With the causes and ethical certification of off-label drug use as a starting point,it holds to the premise of strictly controlling the applicable conditions of off-label drug use and brings forward countermeasures of laws and regulations for the following three aspects:the realization of legal involvement and cohesion of off-label drug use,the issue of unified standards for evidence-based medicine and the encouragement of updating and replacing drug specifications.

Off-label drug use,being urgent and rational under certain circumstances,has existed in clinical practice all the time.While the academic community is divided on this issue,resolving the balance between ensuring the safety of medicines for the public and the availability of medicines for certain groups of the population remains a major concern of the society,but to favour either side is to neglect the defence of the rights of the other side.The implementation of"Law on Practicing Doctors of the People's Republic of China"brings new opportunities and requirements for off-label drug use.With the causes and ethical certification of off-label drug use as a starting point,it holds to the premise of strictly controlling the applicable conditions of off-label drug use and brings forward countermeasures of laws and regulations for the following three aspects:the realization of legal involvement and cohesion of off-label drug use,the issue of unified standards for evidence-based medicine and the encouragement of updating and replacing drug specifications.

Off-label drug use,being urgent and rational under certain circumstances,has existed in clinical practice all the time.While the academic community is divided on this issue,resolving the balance between ensuring the safety of medicines for the public and the availability of medicines for certain groups of the population remains a major concern of the society,but to favour either side is to neglect the defence of the rights of the other side.The implementation of"Law on Practicing Doctors of the People's Republic of China"brings new opportunities and requirements for off-label drug use.With the causes and ethical certification of off-label drug use as a starting point,it holds to the premise of strictly controlling the applicable conditions of off-label drug use and brings forward countermeasures of laws and regulations for the following three aspects:the realization of legal involvement and cohesion of off-label drug use,the issue of unified standards for evidence-based medicine and the encouragement of updating and replacing drug specifications.

Off-label drug use,being urgent and rational under certain circumstances,has existed in clinical practice all the time.While the academic community is divided on this issue,resolving the balance between ensuring the safety of medicines for the public and the availability of medicines for certain groups of the population remains a major concern of the society,but to favour either side is to neglect the defence of the rights of the other side.The implementation of"Law on Practicing Doctors of the People's Republic of China"brings new opportunities and requirements for off-label drug use.With the causes and ethical certification of off-label drug use as a starting point,it holds to the premise of strictly controlling the applicable conditions of off-label drug use and brings forward countermeasures of laws and regulations for the following three aspects:the realization of legal involvement and cohesion of off-label drug use,the issue of unified standards for evidence-based medicine and the encouragement of updating and replacing drug specifications.

Off-label drug use,being urgent and rational under certain circumstances,has existed in clinical practice all the time.While the academic community is divided on this issue,resolving the balance between ensuring the safety of medicines for the public and the availability of medicines for certain groups of the population remains a major concern of the society,but to favour either side is to neglect the defence of the rights of the other side.The implementation of"Law on Practicing Doctors of the People's Republic of China"brings new opportunities and requirements for off-label drug use.With the causes and ethical certification of off-label drug use as a starting point,it holds to the premise of strictly controlling the applicable conditions of off-label drug use and brings forward countermeasures of laws and regulations for the following three aspects:the realization of legal involvement and cohesion of off-label drug use,the issue of unified standards for evidence-based medicine and the encouragement of updating and replacing drug specifications.